Skip to content

The deal

Type
Funding
Amount
$55M
Status
Closed
Round
Series A
Post-money
Not recorded
Region
United States
Date
12 September 2023

As of this development: a later development may record new terms.

Lifecycle

  1. AnnouncedNot recorded
  2. Closed12 September 2023 · This development

Investors in this round

Canaan · Lead investor

First round with Actio Biosciences

DROIA Ventures · Lead investor

First round with Actio Biosciences

Deerfield Management · Investor

First round with Actio Biosciences

EcoR1 · Investor

First round with Actio Biosciences

Euclidean Capital · Investor

First round with Actio Biosciences

Ownership and exit

Acquired by Jazz Pharmaceuticals

15 September 2026 · Acquisition · Closed · after 1 round since 2023 · The deal

Minutes shows stakes only when a party discloses them.

The parties

Actio Biosciences Issuer

2 developments · 2 deals in Minutes

Canaan Lead investor

1 development · 1 deal in Minutes

DROIA Ventures Lead investor

1 development · 1 deal in Minutes

Deerfield Management Investor

1 development · 1 deal in Minutes

More in Healthcare

Past 3 months in Activity →